Antimycobacterial drugs
Download
Report
Transcript Antimycobacterial drugs
Antimycobacterial drugs
First
line of drugs:
Isoniazid (INH)
Rifampicin
Ethambutol
Streptomycin
Pyrazinamide
Never use a single drug therapy
–rifampicin combination administered
for 9 months will cure 95-98% of cases .
Addition of pyrazinamide for this combination for
the first 2 months allows total duration to be
reduced to 6 months.
Isoniazid
Isoniazid
Bacteriostatic
at low conc. & bacteriocidal at high
conc. Especially against actively growing bacteria.
Inhibits synthesis of mycolic acid is an essential
components of mycobacterial cell wall.
Pharmacokinetics
Readily
absorbed from GIT.
Diffuse into all body fluids and tissues
Penetrates caseous material and macrophages so it
is effective against intra and extracellular
organisms.
Metabolized in liver by acetylation
Excreted mainly in urine
Clinical uses
Mycobacterial
infections (it is recommended to be
given with pyridoxine to avoid neuropathy).
Latent tuberculosis in patients with positive
tuberculin skin test
Prophylaxis against active TB in individuals who
are in great risk as very young or
immunocompromised individuals.
Adverse effects
Peripheral neuritis
Optic neuritis.
Allergic reactions ( fever,skin rash,systemic lupus
erythematosus )
Hepatitis
Gastric upset
Haemolytic anaemia
Enzyme inhibitor
CNS toxicity.
Rifampicin
Bactericidal
,binds strongly to β subunit of
bacterial DNA-dependent RNA polymerase
leading to inhibition of RNA synthesis .
Pharmacokinetics
Well
absorbed orall.
Excreted mainly through liver into bile.
Highly protein bind .
Penetrates macrophages so affect extra and
intracellular organisms.
Adequate CSF conc. Only in meningeal
inflammation.
Clinical uses
Mycobacterial
infections
Prophylaxis in contacts of children with
Haemophilus influenzae type b disease.
Treatment of serious staphylococcal infections as
osteomyelitis and endocarditis.
Meningitis by highly resistant penicillin
pneumococci
Adverse effects
Harmless red-orange colour to urine,sweat,tears,contact
lenses.
Rashes
Thrombocytopenia
Nephritis
Cholestatic jaundice,hepatitis
Flu-like syndrome
Induce cytochrome p-450
Ethambutol
Inhibits mycobacterial cell wall synthesis by inhibiting
arabinosyl transferase .
Bacteriostatic
Active against intra&extracellular bacilli .
Well absorbed from gut.
20% excreted in feces and 50% in urine in unchanged
form.
Crosses BBB in meningitis
Used only in mycobacterial infections.
Adverse effects
Retrobulbar
(optic) neuritis causing loss of visual
acuity and red-green colour blindness.
It is relatively contraindicated in children.
GIT .upset .
Hyperuricemia
Pyrazinamide
It
is converted to pyrazinoic acid ,the active form
(prodrug)
Mechanism is unknown.
Bactericidal
Acting on intracellular organisms.
Well absorbed orally ,metabolized in liver
,excreted mainly through kidney .
Clinical uses
Mycobacterial
infections (TB) mainly in multidrug
resistance cases.
It is important in short –course (6 months)
regimens with isoniazid and rifampicin.
Prophylaxis of TB in combination with
ciprofloxacin.
Adverse effects
Hepatotoxic
Hyperuricemia(
provoke acute gouty arthritis )
Nausea & vomiting
Drug fever & skin rash
Streptomycin
Life
threating forms of TB ( meningitis,
dissiminated disease).
Resistant cases (Multidrug resistance tuberculosis
at least to INH & rifampicin ) .
Amikacin
can be used as alternative to
streptomycin.
Both active mainly against extracellular bacilli.
Indication of 2nd line treatment
to the drugs of 1st line.
Failure of clinical response
Increase of risky effects.
Patient is not tolerating the drugs first line drugs.
Resistance
Ethionamide
As isoniazid blocks synthesis of mycolic acid .
Available only in oral form.
Metabolized by the liver ,excreted by kidney.
It is poorly tolerated because of :
-intense gastric irritation
-neurologic symptoms
-hepatotoxicity
Used in TB & leprosy.
Capreomycin
It
is an important injectable agent for treatment of
drug-resistant tuberculosis.
It is nephrotoxic and ototoxic.
Local pain & sterile abscesses may occur.
Cycloserine
Inhibitor
of cell wall synthesis
Cleared renally
The most serious side effects are peripheral
neuropathy and CNS dysfunction, including
depression & psychotic reaction.
Pyridoxine should be given.
Contraindicated in epileptic patients.
Amikacin
Used
as alternative to streptomycin.
Used in multidrug- resistance tuberculosis.
No cross resistance between streptomycin and
amikacin.
Ciprofloxacin & levofloxacin
Effective
against typical and atypical
mycobacteria.
Used against resistant strains.
Used in combination with other drugs.
Rifapentine
As
rifampicin , it is RNA polymerase inhibitor.
Cross resistance with rifampicin.
Potent inducer of cytochrome p450.
Effective against typical and atypical
mycobacteria.
Aminosalicylic Acid (PAS).
Similar in structure to sulfonamide and p-aminobenzoic
acid.
Folate synthesis inhibitor.
Well absorbed from GIT.
Widely distributed in tissues except CSF.
Excreted in urine as active and as metabolic products.
Causes crystalluria,anorexia,nausea,diarrhea,epigastric
pain.
Peptic ulcer and haemorrhage can occur.
Hypersensitivity reactions.
Drugs used in leprosy
Dapsone
Inhibits
folate synthesis.
Well absorbed orally,widely distributed .
Half-life 1-2 days,tends to be retained in
skin,muscle,liver and kidney.
Excreted into bile and reabsorbed in the intestine.
Excreted in urine as acetylated.
It is well tolerated.
Clinical uses
Tuberculoid
leprosy.
Lepromatous leprosy in combination with rifampin
& clofazimine.
To prevent & treat Pneumocystis pneumonia in
AIDS caused by Pneumocystis jiroveci (
Pneumocystis carinii).
Adverse effects
Haemolytic
anaemia
Methemoglobinemia
Gastrointestinal intolerance
Fever,pruritus,rashes.
Erythema nodosum leprosum
Clofazimine
It is a phenazine dye.
Unknown mechanism of action ,may be DNA binding.
Antiinflammatory effect.
Absorption from the gut is variable.
Given orally , once daily.
Excreted mainly in feces.
Stored mainly in reticuloendothelial tissues and skin.
Half-life 2 months.
Delayed onset of action (6 weeks).
Clinical uses
Multidrug
resistance TB.
Lepromatous leprosy
Tuberculoid leprosy in :
patients intolerant to sulfones
dapsone-resistant bacilli.
Chronic skin ulcers caused by M.ulcerans.
Adverse effects
Skin
discoloration ranging from red-brown to black.
Gastrointestinal intolerance.
Red colour urine.
Eosinophilic enteritis
Treatment of TB in pregnant women
INH
( pyridoxine should be given ),
Rifampicin , ethambutol
Pyrazinamide is given only if :
Resistant to other drugs is documented
Streptomycin is contraindicated.
Breast feeding is not contraindication to receive
drugs , but caution should be observed.